Armata Pharmaceuticals (ARMP) Restructuring Costs (2024 - 2026)

Armata Pharmaceuticals has disclosed Restructuring Costs across 3 years of filings, most recently posting $2.0 million for Q1 2026.

• Restructuring Costs for Q1 2026 came in at $2.0 million, up 8.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.7 million (down 2.49% YoY), and the FY2025 annual result was $7.5 million, down 8.93% from the prior year.
• Restructuring Costs came in at $2.0 million for Q1 2026 at Armata Pharmaceuticals, down from $2.3 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $2.3 million in Q4 2025 to a low of $1.4 million in Q2 2025.
• The 3-year median for Restructuring Costs is $2.0 million (2024), against an average of $2.0 million.
• Across the five-year window, Restructuring Costs slipped 23.55% in 2025 and rose 8.05% in 2026, its largest moves.
• Armata Pharmaceuticals' Restructuring Costs stood at $2.2 million in 2024, then grew by 4.43% to $2.3 million in 2025, then dropped by 11.54% to $2.0 million in 2026.
• The last three Restructuring Costs figures came in at $2.0 million (Q1 2026), $2.3 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.